MedTrace Logo

Evaluation of Capillary Blood Collection Devices (Mitra® and HemaPEN®)

NCT05894122 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2023-12-22

No results posted yet for this study

Summary

The aim is to demonstrate a new application for a blood collection device. This device is already widely used in pharmacology. It is not currently used for metabolic diseases.

Its ease of use enables repeated sampling at home. What's more, the device can be sent by post, making it ideally suited to the needs of this cohort of children, whose phenylalanine levels need to be monitored very regularly.

Conditions

Interventions

DIAGNOSTIC_TEST

DM-DIV MITRA®

Comparison of phenylalanine concentrations in the new device with those in the current device (blotter).

Sponsors & Collaborators

  • University Hospital, Grenoble

    lead OTHER

Eligibility

Min Age
3 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-13
Primary Completion
2025-12-12
Completion
2025-12-12

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05894122 on ClinicalTrials.gov